Novel pembrolizumab-based treatments as first-line therapy in advanced clear-cell renal cell carcinoma: substudy 03A of the open-label, umbrella platform, phase I/II KEYMAKER-U03 trial

Cristina Suárez, Carlos Rojas, Saeam Shin, Patricio Yañez Weber, Laurence Albigès, Robert J. Motzer, Hans J. Hammers, A. Peer, Jia-Lin Lee, Wilson H. Miller, T. Waddell, Victoria Neiman, D. Keizman, Alex Kloster, Andrew Weickhardt, R. Dziadziuszko, Leah Suttner, M. Sharma, Joseph E. Burgents, T. Powles